CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
Conditions: LMS - Leiomyosarcoma; Uterine Leiomyosarcoma Interventions: Drug: Gemcitabine; Drug: Dacarbazine; Procedure: Cytoreductive Surgery; Behavioral: Functional Assessment of Cancer Therapy (FACT) G questionnaire; Procedure: Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) Scan; Drug: Gadolinium Sponsor: Stanford University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cancer Therapy | Chemotherapy | CT Scan | Leiomyosarcoma | MRI Scan | PET Scan | Research